Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Correlation of multiple sclerosis (MS) incidence trends with solar and geomagnetic indices: Time to revise the method of reporting MS epidemiological data.
Preclinical and early clinical development of GNbAC1, a humanized IgG4 monoclonal antibody targeting endogenous retroviral MSRV-Env protein.
Multiple sclerosis: Quadrivalent HPV vaccination does not increase risk of MS.
Anthocyanins suppress the secretion of proinflammatory mediators and oxidative stress, and restore ion pump activities in demyelination.
'The only certain measure of the effectiveness of multiple sclerosis therapy is cerebrospinal neurofilament level - YES'.
Cumulative Review of Thrombotic Microangiopathy, Thrombotic Thrombocytopenic Purpura, and Hemolytic Uremic Syndrome Reports with Subcutaneous Interferon β-1a.
Benign Multiple Sclerosis is Associated with Reduced Thinning of the Retinal Nerve Fiber and Ganglion Cell Layers in Non-Optic-Neuritis Eyes.
Autonomic dysfunction in multiple sclerosis.
Neuromyelitis optica and the evolving spectrum of autoimmune aquaporin-4 channelopathies: a decade later.
Exercise barriers and preferences among women and men with multiple sclerosis.
A Fresh Look at the Potential Mechanisms of Progressive Muscle Relaxation Therapy on Depression in Female Patients With Multiple Sclerosis.
Oligodendrocyte Regeneration and CNS Remyelination Require TACE/ADAM17.
Anti-MOG antibodies with longitudinally extensive transverse myelitis preceded by CLIPPERS.
FTY720 inhibits tumor growth and enhances the tumor-suppressive effect of topotecan in neuroblastoma by interfering with the sphingolipid signaling pathway.
[Relationship between biochemical parameters of cerebrospinal fluid and the course of multiple sclerosis.]
Central adaptation after optic neuritis: Is the whole greater than the sum of its parts?
Clinical and demographic factors affecting disease severity in patients with multiple sclerosis.
[Teriflunomide is a new peroral disease-modifying drug for multiple sclerosis (a review)].
Botulinum neurotoxin-A treatment of lower urinary tract symptoms in multiple sclerosis.
Estrogen induces multiple regulatory B cell subtypes and promotes M2 microglia and neuroprotection during experimental autoimmune encephalomyelitis.
The TIM-3 pathway ameliorates Theiler's murine encephalomyelitis virus-induced demyelinating disease.
Effective communication at the point of multiple sclerosis diagnosis.
CD8+-dependent CNS demyelination following ocular infection of mice with a recombinant HSV-1 expressing murine IL-2.
Redefining Self: Patients' Decision Making About Treatment for Multiple Sclerosis.
Teriflunomide (Aubagio®) for the treatment of multiple sclerosis.

Pages